Chai Discovery

About Chai Discovery

Chai Discovery is a company focused on engineering better molecules using artificial intelligence, with an emphasis on molecular design innovations.

Products & Services

Chai-2:A new series of models for molecular design, specializing in zero-shot antibody design with double-digit hit rates in fully de novo antibody design.

Specialties

Artificial Intelligence Molecular Design Antibody Design

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 130000000 MR: - FA: $130 million FAN: 130000000	D: 2025-12-15 FD: 2025-12-15	12 investors
2	RT: Series A T: - FT: Series A	A: 70000000 MR: - FA: $70 million FAN: 70000000	D: 2025-08-06 FD: 2025-08-06	12 investors

Series B Latest

2025-12-15

$130.0M

12 investors (Pro only)

Series A 2025-08-06

$70.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Chai Discovery Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised